NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. It specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. It has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.
Ticker SymbolNIVF
Company nameNewGenIvf Group Ltd
IPO dateFeb 15, 2022
CEOWing Fung (Siu)
Number of employees76
Security typeOrdinary Share
Fiscal year-endFeb 15
Address13/F, Ps Tower, Sukhumvit 21 Rd (Asoke)
CityBANGKOK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryThailand
Postal code- -
Phone
Websitehttps://newgenivf.com/
Ticker SymbolNIVF
IPO dateFeb 15, 2022
CEOWing Fung (Siu)
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data